BridgeMD
New treatment option for Minor Stroke
Official title Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions
ClinicalTrials.gov ID: NCT04945174
What this study is testing
- What it's testing
- In a randomized controlled trial the effect of 12 weeks of cross-sectorial physical exercise combined with patient education and individual follow-up session is investigated in patients with minor stroke or non-disabling stroke.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with a minor stroke or TIA without the need of rehabilitation after hospital discharge, but need physical activity in order to prevent...
- Patients spending ≤ 5 hour of leisure time on high-intensity physical activity on weekly basis within the last 3 months
- Able to speak and read Danish and to provide informed consent
- Individuals ≥ 18 years of age
You likely can't join if
- Previous large-artery stroke or hemorrhagic stroke
- Unstable cardiac condition, e.g. pacemaker
- Uncontrolled hypertension (patients not responding adequately to antihypertensive medication when applying treatment according to guidelines)
- Symptoms or comorbidities not allowing exercise on a stationary bicycle (e.g. claudication)
- Dyspnoea caused by heart or pulmonary disease (e.g. COPD)
- Aphasia, or dementia that interferer with understanding the protocol and/or physical examinations.
See the full eligibility criteria
- Patients with a minor stroke or TIA without the need of rehabilitation after hospital discharge, but need physical activity in order to prevent cardiovascular diseases
- Patients spending ≤ 5 hour of leisure time on high-intensity physical activity on weekly basis within the last 3 months
- Able to speak and read Danish and to provide informed consent
- Individuals ≥ 18 years of age
- Previous large-artery stroke or hemorrhagic stroke
- Unstable cardiac condition, e.g. pacemaker
- Uncontrolled hypertension (patients not responding adequately to antihypertensive medication when applying treatment according to guidelines)
- Symptoms or comorbidities not allowing exercise on a stationary bicycle (e.g. claudication)
- Dyspnoea caused by heart or pulmonary disease (e.g. COPD)
- Aphasia, or dementia that interferer with understanding the protocol and/or physical examinations.
- Patients diagnosed with dementia at hospital admission (a score ≤23/30 on the Mini-Mental State Examination are not invited into the study)
The study team makes the final eligibility decision.
Where it's taking place
- Copenhagen, Herlev, Denmark
- Herlev, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Copenhagen, Herlev, Denmark; Herlev, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.